Delivery Order SPE2DB20D7061-SPE2DB24FSNV1
Award Date
6/27/24
Potential Completion Date
6/28/24
Potential Value
$6.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,885,038 units of 20 mg Atorvastatin tablets, a cardiovascular medication, with a ceiling value of $2,259.75. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,565,404,327 units of Atorvastatin 20 mg tablets. The contract, valued at $3,596.23, was awarded by the Defense Logistics Agency (DLA) on August 9, 2024, with a completion date of August 12, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award, valued at $2,908.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atorvastatin 20 mg tablets in 1,000-count quantities, with a performance period through January 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,668.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,567,600 units of Atorvastatin 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of March 18, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRQE2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,304.28 firm fixed-price delivery order is for the supply of 4,565,179,182 units of Atorvastatin 20 mg tablets. This contract has an ultimate completion date of July 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of 4,561,450,705 tablets of 80 mg Atorvastatin, a generic cardiovascular medication, to the Defense Logistics Agency (DLA). The $2,184.90 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 10, 2023, with a completion date of July 11, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of 1,000 tablets of 40 mg Atorvastatin, a prescription medication used to treat high cholesterol and related cardiovascular conditions. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract has a ceiling value of $1,897.08 and a completion date of November 15, 2023. It is a firm-fixed-price delivery order...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,502.25 firm-fixed-price contract is for the delivery of Atorvastatin 40 mg tablets. The contract has an ultimate completion date of July 15, 2022 and was awarded on July 14, 2022. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,353.12 firm fixed-price delivery order is for 4,566,798,722 tablets of 20 mg Simvastatin, a common cholesterol medication. The contract has a period of performance through December 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $503,640 firm fixed price delivery order to AmerisourceBergen Drug Corporation for 500 bottles of 20mg atorvastatin tablets. The place of performance is AmerisourceBergen's corporate office and distribution center located in Conshohocken, Pennsylvania. The order is to be completed between July 13-14, 2023. No major subcontractors or set aside designations were identified. The delivery...